Physician profile
Thomas J Wolf
NPI 1669455812
$15,266.58
in general payments reported to CMS, 2019-2025
53 companies · $1,195 in 2025
The $1,195 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,765 · 2020: $1,753 · 2021: $3,192 · 2022: $3,184 · 2023: $1,819 · 2024: $1,359 · 2025: $1,195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,373.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,450.96 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Pfizer INC. | $1,133.27 | 2019-2025 | |
| Novo Nordisk INC | $1,055.15 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $997.78 | 2019-2025 | Evenity, Prolia, Repatha |
| Sanofi-Aventis U.S. LLC | $809.50 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $762.52 | 2019-2025 | Trintellix |
| Lilly USA, LLC | $696.34 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $649.13 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $618.63 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Merck Sharp & Dohme LLC | $596.92 | 2019-2023 | Verquvo, Belsomra |
| Novartis Pharmaceuticals Corporation | $571.47 | 2019-2023 | |
| Allergan, INC. | $488.09 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $444.51 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $425.57 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $307.82 | 2019-2024 | Synjardy, Jardiance, Tradjenta |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $297.87 | 2021 | |
| Esperion Therapeutics, INC. | $294.82 | 2020-2025 | Nexletol |
| Otsuka America Pharmaceutical, INC. | $230.93 | 2020-2025 | Rexulti |
| Eisai INC. | $223.38 | 2020-2024 | |
| Abbott Laboratories | $220.92 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $180.57 | 2019-2025 | Xifaxan |
| Biohaven Pharmaceutical Holding Company Ltd. | $154.30 | 2022 | |
| Corium, LLC | $146.09 | 2022-2024 | Azstarys |
| Medtronic, INC. | $144.78 | 2022-2025 | Inceptiv, Inpen Smart Insulin Delivery System, Intellis Adaptivestim |
| E.R. Squibb & Sons, L.L.C. | $136.63 | 2019-2023 | Eliquis |
| Amarin Pharma, INC. | $116.65 | 2019-2022 | |
| Exact Sciences Corporation | $103.33 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $89.09 | 2023-2025 | Auvelity |
| Astellas Pharma US INC | $88.39 | 2020-2024 | Veozah |
| Phathom Pharmaceuticals, INC. | $74.28 | 2024-2025 | Voquezna |
| Endo Pharmaceuticals INC. | $70.97 | 2021-2023 | Aveed |
| Inari Medical, INC. | $60.06 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Regeneron Healthcare Solutions, INC. | $58.55 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $56.41 | 2025 | Caplyta |
| Mylan Specialty L.P. | $54.66 | 2021 | |
| Boston Scientific Corporation | $45.18 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $42.10 | 2019-2020 | |
| Daiichi Sankyo INC. | $40.12 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $36.39 | 2019-2025 | Austedo Xr |
| Tactile Systems Technology INC | $35.29 | 2022 | |
| Edwards Lifesciences Corporation | $31.75 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Vanda Pharmaceuticals INC. | $25.60 | 2025 | Fanapt |
| Sumitomo Pharma America, INC. | $22.47 | 2023 | Aptiom |
| Ironwood Pharmaceuticals, INC | $22.21 | 2023 | Linzess |
| Verona Pharma, INC. | $22.06 | 2025 | Ohtuvayre |
| Kyowa Kirin, INC. | $21.68 | 2020 | |
| Tris Pharma INC | $21.45 | 2023 | Dyanavel Xr |
| Baxter Healthcare | $19.40 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Corcept Therapeutics | $19.10 | 2024 | Korlym |
| Almatica Pharma LLC | $13.50 | 2022 | |
| Irhythm Technologies, INC. | $13.27 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.22 | 2023 | Quviviq |
| Radius Health, INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.